Total Funding
56
73
Total FundingSeries C raised
Growth Score 56 in past quarter
-20 pts
Heat Score 73 in past quarter
13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
2092
Verge Genomics uses machine learning and human genomics to accelerate drug discovery.
- Alice Zhang: Co-Founder & CEO
- Victor Hanson-Smith: Head of Computational Biology
About the Company
Verge Genomics transforms drug discovery with artificial intelligence. Verge was founded by a unique combination of the field's top machine learning experts and seasoned neuroscience drug developers. Together, they share the vision that exponential advances in computational genomics combined with new insights into neuroscience has created a
breakthrough opportunity to discover drugs that dramatically improve the lives of patients suffering from neurodegenerative disease.
Women Founded
Women Led
